Oncology & Cancer
Study may explain why once-promising cancer drugs failed
Nearly two decades after a class of once-promising cancer drugs called MMP inhibitors mysteriously failed in clinical trials, scientists think they may have an explanation for what went wrong.
Jan 24, 2019
0
25
